This prototype is currently only available on desktop
Best regards, Odin IR team
Understand Xlife
Understand Xlife Sciences
Latest info
Financial highlights
At a glance
Strategic Pillars
Why invest?
Business Segments
Mission & Vision
Business model
Investment Process
Projects
Projects
Technology & Platforms
Biotech & Therapies
Medical Technology
Artificial Intelligence
Financials
Financials
Financial reports
Financial calendar
Analysts
The share & financials
Investor Presentation
Data
Key figures, shareholders, & the share
Governance
Governance
Management, Team & Board of Directors
Advisory Board
Resolutions
Statutes
News & media
News & media
News
Investor Presentation
Subscribe
ESG
ESG
Sustainability at Xlife sciences
Our ESG Journey
Sustainability Reports
Code of Conduct
Contact
Suggested searches
Reports
Governance
Sustainability
EN
DE
EN
DE
Contact us
Contact us using this form, or reach out to one of the contacts listed on the right
Agree to privacy policy
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Xlife Sciences AG
Talacker 35
8001 Zürich
Switzerland
+41 44 385 84 60
info@xlifesciences.ch
+46 76 068 29 90
Investors & Media
Dr. Dennis Fink
dennis.fink@xlifesciences.ch
+46 76 068 29 90
Scientific Contact & Projects
Dr. Alexander Zink
alexander.zink@xlifesciences.ch
+46 76 068 29 90
Xlife Sciences USA
Dr. Frank Plöger
frank.ploeger@xlifesciences.ch
+46 76 068 29 90
Oliver R. Baumann, CEO
Get regular updates about Xlife Sciences
Press releases
Ad Hoc
Newsletter
German
English
Agree to privacy policy
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Continue learning
Download latest report
Half-Year Report 2025
Download latest report
Halbjahresbericht 2025
Financials
Governance
Sustainability
News & media